TOD'S S.p.A. (TODGF)
USD 37.65
(0.0%)
USD 37.65
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 132.98 Million | 129.33 Million | 225.96 Million | -2.67 Million | 110.6 Million | 29.13 Million |
| Net Income | 50.01 Million | 23.06 Million | -6.74 Million | -89.55 Million | 51.95 Million | 54.01 Million |
| Depreciation & Amortization | 164.77 Million | 140.4 Million | -151.17 Million | -177.12 Million | -167.42 Million | 43.27 Million |
| Deferred income taxes | - | 1.09 Million | 8.41 Million | -108.49 Million | 1.16 Million | - |
| Stock-based compensation | - | 302.29 Million | 288.76 Million | 338.1 Million | 319.44 Million | - |
| Change in working capital | -94.58 Million | -29.36 Million | 70.96 Million | -26.06 Million | -39.93 Million | -61.51 Million |
| Other non-cash items | 21.82 Million | -308.15 Million | 15.74 Million | 60.45 Million | -54.58 Million | -6.63 Million |
| Investing Cash Flow | -54.79 Million | -44.42 Million | -49.83 Million | -36.33 Million | 104.07 Million | -70.58 Million |
| Investments in PPE | -55.77 Million | -45.84 Million | -51.07 Million | -37.03 Million | -54.64 Million | -47.1 Million |
| Acquisitions | - | 1.51 Million | 1.23 Million | 699.87 Thousand | - | -22.16 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -13.88 Million | -99.68 Thousand | 0.96 | 0.55 | 158.72 Million | -1.31 Million |
| Financing Cash Flow | -170.71 Million | -143.71 Million | -297.68 Million | 230.24 Million | -225.28 Million | 5.48 Million |
| Debt repayment | -60 Million | -43.35 Million | -190.15 Million | -324.49 Million | -85.26 Million | -58.55 Million |
| Dividends payments | - | - | - | - | -33.09 Million | -53.07 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 1.00 | -100.36 Million | -107.53 Million | 554.74 Million | -102.87 Million | - |
| Accounts receivables | -13.57 Million | -9.95 Million | -13.79 Million | 29.68 Million | 5.06 Million | 6.88 Million |
| Accounts payables | - | 41.05 Million | 30.64 Million | -39.05 Million | -13.24 Million | - |
| Inventory | -67.92 Million | -41.69 Million | 46.55 Million | -9.01 Million | -31.82 Million | -60.3 Million |
| Other working capital | -9.11 Million | -18.76 Million | 7.55 Million | -7.68 Million | 67.35 Thousand | -8.09 Million |
| Cash at beginning of period | 160.64 Million | 215.7 Million | 316.17 Million | 160.6 Million | 173.34 Million | 246.78 Million |
| Cash at end of period | 78.46 Million | 160.64 Million | 215.7 Million | 316.17 Million | 160.6 Million | 198.58 Million |
| Capital Expenditure | -55.77 Million | -45.84 Million | -51.07 Million | -37.03 Million | -54.64 Million | -47.1 Million |
| Effect of forex changes on cash | 10.35 Million | 3.75 Million | 6.47 Million | -733 Thousand | -3.29 Million | -1.09 Million |
| Net cash flow / Change in cash | -82.18 Million | -55.05 Million | -100.46 Million | 155.56 Million | -12.73 Million | -48.2 Million |
| Free Cash Flow | 77.2 Million | 83.48 Million | 174.89 Million | -39.71 Million | 55.96 Million | -17.96 Million |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 21.04 Million | 50.01 Million | 33.75 Million | 23.06 Million | 23.87 Million | 791.24 Thousand |
| Depreciation & Amortization | 87.73 Million | 164.77 Million | 85.59 Million | 140.4 Million | 80.16 Million | 76.38 Million |
| Deferred income taxes | 11.06 Million | - | - | 1.09 Million | 1.09 Million | - |
| Stock-based compensation | - | - | - | 302.29 Million | 152.75 Million | - |
| Change in working capital | -26.02 Million | -94.58 Million | -77.44 Million | -29.36 Million | -3.27 Million | -27.56 Million |
| Other non-cash items | 200.65 Million | 21.82 Million | 249.15 Million | -308.15 Million | 139.46 Million | 172.63 Million |
| Investing Cash Flow | -37.73 Million | -54.79 Million | -22.48 Million | -44.42 Million | -30.09 Million | -17.08 Million |
| Investments in PPE | -38.08 Million | -55.77 Million | -23.2 Million | -45.84 Million | -30.91 Million | -17.77 Million |
| Acquisitions | 349.88 Thousand | - | 720.97 Thousand | 1.51 Million | 819.81 Thousand | 684.34 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 1.00 | -13.88 Million | - | -99.68 Thousand | 1.00 | - |
| Financing Cash Flow | -97.09 Million | -170.71 Million | -90.25 Million | -143.71 Million | -79.06 Million | -73.19 Million |
| Debt repayment | -33.11 Million | -60 Million | -32.72 Million | -43.35 Million | -23.76 Million | -22.16 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -63.98 Million | 1.00 | -57.53 Million | -100.36 Million | -55.29 Million | - |
| Accounts receivables | -17.5 Million | -13.57 Million | 3.88 Million | -9.95 Million | -8.96 Million | -977.78 Thousand |
| Accounts payables | 15.79 Million | - | -20.52 Million | 41.05 Million | 32.43 Million | 8.44 Million |
| Inventory | -19.1 Million | -67.92 Million | -55.2 Million | -41.69 Million | -13.98 Million | -30 Million |
| Other working capital | -5.2 Million | -9.11 Million | -5.59 Million | -18.76 Million | -12.76 Million | -5.02 Million |
| Cash at beginning of period | 122.63 Million | 160.64 Million | 179.49 Million | 215.7 Million | 194.42 Million | 253.82 Million |
| Cash at end of period | 93.61 Million | 78.46 Million | 122.63 Million | 160.64 Million | 179.49 Million | 194.42 Million |
| Capital Expenditure | -38.08 Million | -55.77 Million | -23.2 Million | -45.84 Million | -30.91 Million | -17.77 Million |
| Effect of forex changes on cash | 7.61 Million | 10.35 Million | -0.56 | 3.75 Million | -1.00 | -16.05 Million |
| Net cash flow / Change in cash | -29.02 Million | -82.18 Million | -56.85 Million | -55.05 Million | -14.93 Million | -59.4 Million |
| Free Cash Flow | 60.1 Million | 77.2 Million | 24.8 Million | 83.48 Million | 59.56 Million | 29.16 Million |
EM
LAVV3
MEDS
VVIVF
112040
9262